Perhaps unsurprisingly the top stories during 2023 were related to the availability, or otherwise, of medications. The nationwide shortage of Ozempic hit the headlines at the start of 2023, and concerns still remain high for those struggling to access a regular supply. Several months later the potential withdrawal of Fiasp from the PBS understandingly sparked angst and distress in the community. These two issues were a major driving force behind the launch of our Spark Change platform. We have committed to fight for change on these issues, plus others. We urge you to add your voice on topics that concern you here.

While Ozempic and Fiasp took out the top two spots for the most read articles on our website in 2023, the following eight articles were not far behind.